Optimization of peptide-based cancer vaccine compositions, by sequential screening, using versatile liposomal platform-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Optimization of peptide-based cancer vaccine compositions, by sequential screening, using versatile liposomal platform

Published:2019-05 Issue: Volume:562 Page:342-350
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Jacoberger-Foissac Célia,Saliba Hanadi,Seguin Cendrine,Brion Anaïs,Kakhi Zahra,Frisch Benoît,Fournel Sylvie,Heurtault Béatrice

Funder

CNRS

University of Strasbourg

french Ministère de l'Education Nationale

de la Recherche et de la Technologie

La Ligue contre le Cancer

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference52 articles.

1. Targeting CD4+ T-helper cells improves the induction of antitumor responses in dendritic cell-based vaccination;Aarntzen;Cancer Res.,2013

2. Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides;Alexander;Immunity,1994

3. Cancer vaccine adjuvants – recent clinical progress and future perspectives;Banday;Immunopharmacol. Immunotoxicol.,2015

4. Immunization with a tumor-associated CTL epitope plus a tumor-related or unrelated Th1 helper peptide elicits protective CTL immunity;Casares;Eur. J. Immunol.,2001

5. Platform technologies for modern vaccine manufacturing;Charlton Hume;Vaccine,2017

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid- and Polymer-Based Nanocarrier Platforms for Cancer Vaccine Delivery;ACS Applied Bio Materials;2024-01-18

2. Advanced nanovaccines based on engineering nanomaterials for accurately enhanced cancer immunotherapy;Coordination Chemistry Reviews;2022-12

3. Nucleotide-Binding Oligomerization Domain 1/Toll-Like Receptor 4 Co-Engagement Promotes Non-Specific Immune Response Against K562 Cancer Cells;Frontiers in Pharmacology;2022-07-22

4. Surface Modification of Lipid-Based Nanoparticles;ACS Nano;2022-04-21

5. Peptide-Based Nanovaccines in the Treatment of Cervical Cancer: A Review of Recent Advances;International Journal of Nanomedicine;2022-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3